Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

RECRUITING
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
Description

To learn if giving nivolumab in combination with relatlimab can help to control melanoma that has spread to the brain (melanoma with brain metastases). The safety and side effects of the study drug combination will also be studied.

Conditions
TERMINATED
Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases
Description

The purpose of this study is to evaluate the effectiveness of the combination of vemurafenib with cobimetinib in patients with active melanoma brain metastases.